300416.SZ
苏试试验
SZSE · M 科研服务 · CN
CNY 14.34
−2.45%Year over year
Reported trailing growth
- Revenue
- +13.6%
- EBITDA
- —
- EBIT
- +7.4%
- EPS
- +14.0%
- Free cash flow
- +20.2%
- Operating cash flow
- +32.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +7.6%
- EBITDA
- +4.5%
- EBIT
- -1.5%
- Net income
- -1.6%
- EPS
- -3.4%
- Free cash flow
- +36.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026